Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine

Psychiatric Genetics

Volumn 20, Issue 3, 2010, Pages 85-92

  Hamidovic, Ajna ^a   Dlugos, Andrea ^a   Palmer, Abraham A ^a   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamine; Cognition; COMT; DevMod; DSST; Lapses in attention; Rs4680

Indexed keywords

AMPHETAMINE; CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; ATTENTION; BRAIN REGION; CAUCASIAN; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXTRAVERSION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NORMAL HUMAN; OUTCOME ASSESSMENT; PERSONALITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE; WORKING MEMORY;

ADOLESCENT; ADULT; AFFECT; AMINO ACID SUBSTITUTION; AMPHETAMINE; AREA UNDER CURVE; ATTENTION; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 77953809083     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833a1f3c     Document Type: Article

References (35)

1. Acheson A, de Wit H (2008). Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol 16:113-123.
2. Acheson A, Richards JB, de Wit H (2007). Effects of sleep deprivation on impulsive behaviors in men and women. Physiol Behav 91:579-587.
3. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Press.
4. Castellanos F, Sonuga-Barke E, Scheres A, Di Martino A, Hyde C,Walters J, et al. (2005). Varieties of attention-deficit/hyperactivity disorder-related intraindividual variability. Biol Psychiatry 57:1416-1423.
5. Childs E, de Wit H (2008). Enhanced mood and psychomotor performance by a caffeine-containing energy capsule in fatigued individuals. Exp Clin Psychopharmacol 16:13-21.
6. Czeisler C, Walsh J, Roth T, Hughes R, Wright K, Kingsbury L, et al. (2005). Modafinil for excessive sleepiness associated with shift-work sleep disorders. N Engl J Med 353:347-486.
7. De Wit H (2009). Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 14:22-31.
8. Derogatis L (1983). SLC-90-R manual II. Towson, MD: Clinical Psychometric Research.
9. Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, et al. (2007). Norepinephrine transporter gene variation modulates acute response to d-amphetamine. Biol Psychiatry 61:1296-1305.
10. Dockree P, Bellgrove M, O'Keeffe F, Moloney P, Aimola L, Simone C, et al. (2006). Sustained attention in traumatic brain injury (TBI) and healthy controls: enhanced sensitivity with dual task load. Exp Brain Res 168:218-229.
11. Egan M, Goldberg T, Kolachana B, Callicott JH, Mazzanti C, Straub R, et al. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917-6922.
12. Enoch MA, Waheed JF, Harris CR, Albaugh B, Goldman D (2009). COMT Val158Met and cognition: main effects and interaction with educational attainment. Genes Brain Behav 8:36-42.
13. Hettema JM, An SS, Bukszar J, Van den Oord E, Neale MC, Kendler KS, et al. (2008). Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 64:302-310.
14. Hodgkinson CA, Yuan QP, Xu K, Shen PH, Heinz E, Lobos EA, et al. (2008). Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43:505-515.
15. Karoum F, Chrapusta S, Egan M (1994). 3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63:972-979.
16. Lachman H, Papolos D, Saito T, Yu Y, Szumlanski L, Weinshilboum M (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
17. Leth-Steensen C, Elbaz Z, Douglas V (2000). Mean response times, variability and skew in the responding of ADHD children: a response time distributional approach. Acta Psycho 104:167-190.
18. Lott D, Kim S, Cook E, De Wit H (2005). Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30:602-609.
19. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Mele'n K, Julkunen I, et al. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
20. Matthews JNS, Altman DG, Campbell MJ, Royston P (1990). Analysis of serial measurements in medical research. Br Med J 300:230-235. (Pubitemid 20045528)
21. Mattay V, Goldberg T, Fera F, Hariri A, Tessitore A, Egan MF, et al. (2003). COMT val158met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100:6186-6191.
22. McNair D, Lorr M, Droppleman L (1971). Profile of mood states. San Diego: Educational and Industrial Testing Service.
23. Parkin A, Java R (1999). Deterioration of frontal lobe function in normal aging: influences of fluid intelligence versus perceptual speed. Neuropsychology 13:539-545.
24. Pritchard JK, Stephens M, Donnelly P (2000). Inference of population structure using multilocus genotype data. Genetics 155:945-959.
25. Reimer B, D'Ambrosio L, Gilbert J, Coughlin J, Biederman, J, Surman C, et al. (2005). Behavior differences in drivers with attention deficit hyperactivity disorder: the driving behavior questionnaire. Accid Anal Prev 37:996-1004.
26. Selzer M (1971). The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653-1658.
27. Spencer S, Hawk L, Richards J, Shiels K, Pelham W, Waxmonsky J (2009). Stimulant treatment reduces lapses in attention among children with ADHD: the Effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol 37:805-816.
28. Stein M, Fallin M, Schork N, Gelernter J (2005). COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30: 2092-2102.
29. Tellegen A (1982). Multidimensional pesonality questionnaire manual. Minneapolis, MN: University of Minnesota Press.
30. Tellegen A (1988). The analysis of consistency in personality assessment. J Person 56:621-663.
31. Tunbridge E, Harrison P, Weinberger D (2006). Catechol-O- methyltransferase, cognition, and psychosis: Val158Met and Beyo. Biol Psychiatry 60:141-151.
32. Vilkki J, Holst P (1991). Mental programming after frontal lobe lesions: results on digit symbol performance with self-selected goals. Cortex 27:203-211.
33. Volkow N, Wang G, Fowler J, Logan J, Angrist B, Hitzemann R, et al. (1997). Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154:50-65.
34. White T, Justice A, de Wit H (2002). Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73:729-741.
35. Wechsler D (1958). The measure and appraisal of adult intelligence. Baltimore: Williams and Wilkins.